Oncology & Cancer

Study provides clinician guidance on follow-up for ovarian cysts

About 15 to 20% of women will develop an ovarian cyst during their lifetime. The fluid-filled or solid sacs in the ovaries are usually non-cancerous and go away independently—studies show that about 85% resolve within five ...

Oncology & Cancer

The role of fibronectin in BRAF-mutant thyroid cancer treatment

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...

Oncology & Cancer

Early diagnosis of high-grade serous ovarian cancer feasible

Early diagnosis of high-grade serous ovarian cancer (HGSOC) seems feasible through analysis of genomic alterations in DNA from Papanicolaou (Pap) test smears, according to a study published online Dec. 6 in Science Translational ...

page 4 from 40